Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized double-blind trial of inactivated split virion influenza vaccine in individuals aged 9 years and above
CTR20244011Phase 4Active
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- Oct 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in influenza comparing Influenza vaccine arm with PBS placebo arm (2 arms). Primary endpoint: Incidence of laboratory-confirmed influenza cases by RT-qPCR. Started Oct 2024; status: active.
02
Drugs
influenza vaccine (split virion, inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20244011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244011.